- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dr. Hoenle AG O.N. (HNL)
Track today's live Dr. Hoenle AG (HNL) share price, performance and key data on this page with our current Xetra:HNL stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Dr. Hoenle AG share price on the Xetra exchange. Use the dropdown to switch exchange for the HNL share price, head to our technical summary section, which provides analysis on Dr. Hoenle AG share price buy/sell indicators using real-time data (or discuss the Dr. Hoenle AG (HNL) stock price today with other investors in the Dr. Hoenle AG ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR:HNL share price (ISIN: DE0005157101) to enhance your trading decisions with our free investment tools and resources.
What Is the Dr. Hoenle AG O.N. Share Price Today?
The Dr. Hoenle AG share price today is 8.180.
What Is the Stock Symbol for Dr. Hoenle AG O.N.
The stock symbol (or 'ticker') for Dr. Hoenle AG O.N. is "HNL."
What Stock Exchange Does Dr. Hoenle AG O.N. Trade On?
Dr. Hoenle AG O.N. is listed and trades on the Xetra stock exchange.
Is Dr. Hoenle AG O.N. a Good Stock to Buy?
Determining whether Dr. Hoenle AG (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ETR:HNL share price (ISIN: DE0005157101) to enhance your trading decisions with our free investment tools and resources.
What Is the Dr. Hoenle AG O.N. Share Price Today?
The Dr. Hoenle AG share price today is 8.180.
What Is the Stock Symbol for Dr. Hoenle AG O.N.
The stock symbol (or 'ticker') for Dr. Hoenle AG O.N. is "HNL."
What Stock Exchange Does Dr. Hoenle AG O.N. Trade On?
Dr. Hoenle AG O.N. is listed and trades on the Xetra stock exchange.
Is Dr. Hoenle AG O.N. a Good Stock to Buy?
Determining whether Dr. Hoenle AG (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
8.180
+0.060(+0.74%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.000
8.300
52 wk Range
6.480
10.400
HNL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.0008.300
52 wk Range
6.48010.400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HNL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
16.333
Upside
+99.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 16.333
(+99.67% Upside)
Dr. Hoenle AG O.N. Earnings Call Summary for Q3/2026
- Q3 revenue rose 4.9% to EUR 23.7M; EBITDA surged to EUR 1.7M from EUR 0.5M, lifting margin to 7.3% from 2.2% year-over-year.
- Nine-month EBITDA climbed 26% to EUR 4.5M despite flat revenue at EUR 69M, driven by cost discipline and improved product mix.
- Full-year guidance unchanged at EUR 92-95M revenue and EUR 5-6M EBITDA; Q4 EBITDA margin expected between 6-7.3%.
- Curing division remains pressured by weak equipment demand but expected to return to growth in fiscal 2026-2027 and reach EBITDA break-even within a year.
- Operating cash flow improved 23% to EUR 4.6M; net debt reduced to EUR 37.4M from EUR 38.4M, with equity ratio at 53%.
Last Updated: 18/08/2026, 13:40
Read Full TranscriptEarnings
Latest Release
18/08/2026
EPS / Forecast
-0.04 / --
Revenue / Forecast
23.7M / --
Compare HNL to Peers and Sector
Metrics to compare | HNL | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipHNLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −17.0x | −3.0x | 11.9x | |
PEG Ratio | −0.22 | 0.01 | 0.03 | |
Price/Book | 0.7x | 4.8x | 1.4x | |
Price / LTM Sales | 0.5x | 1.1x | 1.2x | |
Upside (Analyst Target) | 107.8% | 40.1% | 27.7% | |
Fair Value Upside | Unlock | 14.8% | 8.0% | Unlock |
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives applications. The Curing segment sells equipment for surface drying and curing paints, varnishes, and other coatings for printing, packaging printing, coating, and printing on three dimensional objects industries. The Disinfection segment is involved in activities in the areas of industrial water, surface, and air disinfection, including microbiological testing for various applications comprising disinfection in food industry, special lamps for life science, custom lamps, and microbiologic analyses. It serves aerospace, automotive, consumer electronics, environmental, food, health and medical technology, print, and semiconductor industries. The company was formerly known as Dr. Hönle AG and changed its name to Hoenle AG. The company was founded in 1976 and is headquartered in Gilching, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Dr. Hoenle AG (Xetra: HNL) Share Price Today?
The Dr. Hoenle AG stock price today is 8.180 EUR.
What Stock Exchange Does Dr. Hoenle AG (HNL) Trade On?
Dr. Hoenle AG is listed and trades on the Frankfurt Stock Exchange.
What Is the Ticker (Stock Symbol) for Dr. Hoenle AG?
The stock symbol (also called a 'ticker') for Dr. Hoenle AG is "HNL."
What Is the Current Dr. Hoenle AG Market Capitalisation?
As of today, Dr. Hoenle AG (Xetra: HNL) market cap is 49.590M EUR.
What Is Dr. Hoenle AG's (HNL) Earnings Per Share (TTM)?
The Dr. Hoenle AG EPS is currently -0.480 (Trailing Twelve Months).
When Is the Next Dr. Hoenle AG Earnings Date?
Dr. Hoenle AG's next earnings report will be released on 19/08/2026.
Is HNL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Dr. Hoenle AG moving averages and other technical indicators, the daily buy/sell signal for HNL stock is Neutral.
How Many Times Has Dr. Hoenle AG Stock Split?
Dr. Hoenle AG has split 0 times. (See the HNL stock split history page for full effective split date and price information.)
How Many Employees Does Dr. Hoenle AG Have?
Dr. Hoenle AG has 528 employees, based on their latest Companies House report.
What is the current trading status of Dr. Hoenle AG (Xetra: HNL)?
As of 24/08/2026, Dr. Hoenle AG (HNL) is trading at a share price of 8.180 EUR, with a previous close of 8.120 EUR. The stock has fluctuated within a day range of 8.000 EUR to 8.300 EUR, while its 52-week range spans from 6.480 EUR to 10.400 EUR.
What Is Dr. Hoenle AG (HNL) Price Target According to Analysts?
The average 12-month price target for Dr. Hoenle AG is 16.333 EUR, with a high estimate of 18 EUR and a low estimate of 14 EUR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +99.67% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.